Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?

다국어 초록 (Multilingual Abstract)

Objective: Human papillomavirus (HPV) testing is widely incorporated into cervical cancer screening strategies. Current screening requires pelvic examination for cervical sampling, which may compromise participation. The acceptance could be raised by introducing testing on vaginal swabs. We explored the interchangeability of vaginal swabs and cervical smears for HPV testing, by means of a prospective study conducted in female sex workers (FSWs). Besides, we report on the occurrence of 32 different HPV genotypes in FSW with low-grade squamous intraepithelial lesion (LSIL) or high-grade squamous intraepithelial lesion (HSIL).
Methods: Paired physician-collected vaginal swabs and cervical smears from 303 FSW were tested for HPV using the Abbott RealTime High-Risk HPV assay. Cervical cytology was examined on cervical smears. In case of HSIL/LSIL cytological classification (n=52), both samples were genotyped using INNO-LiPa HPV Genotyping Extra II.
Results: The overall prevalence of high-risk (HR)-HPV was 51%. In FSW with HSIL/LSIL cervical cytology, the sensitivity and specificity of vaginal samples for the detection of HR-HPV was 100% and 70% and for probable HR-HPV 100% and 91%. The mean number of genotypes identified in vaginal samples (mean=3.5; 95% confidence interval [CI]=2.8–4.2) was significantly higher than in cervical smear samples (mean=2.6; 95% CI=2.1–3.0) (p=0.001). The most frequently encountered HR-HPV genotypes were HPV16, 31, 51, and 52.
Conclusion: As our study shows that vaginal swabs are equivalent to cervical smears for the detection of (probable) HR-HPV, vaginal swabs can be used for HPV testing in cervical cancer screening strategies. Given the acceptance of vaginal sampling, this finding offers an opportunity to boost screening coverage.

참고문헌 (Reference)

1 Arbyn M, "Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?" 21 : 817-826, 2015

2 Vielot N, "The role of chlamydia trachomatis in high-risk human papillomavirus persistence among female sex workers in Nairobi, Kenya" 42 : 305-311, 2015

3 Landis JR, "The measurement of observer agreement for categorical data" 33 : 159-174, 1977

4 Taylor S, "The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature" 16 : 293-, 2016

5 Satterwhite CL, "Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008" 40 : 187-193, 2013

6 Cwikel JG, "Sexually transmissible infections among female sex workers: an international review with an emphasis on hard-to-access populations" 5 : 9-16, 2008

7 Petignat P, "Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women" 41 : 527-534, 2005

8 Ghosh I, "Prevalence of human papillomavirus and co-existent sexually transmitted infections among female sex workers, men having sex with men and injectable drug abusers from eastern India" 13 : 799-802, 2012

9 Dunne EF, "Prevalence of HPV infection among females in the United States" 297 : 813-819, 2007

10 Peng RR, "Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis" 9 : 113-119, 2012

11 Lorincz A, "New strategies for human papillomavirus-based cervical screening" 9 : 443-452, 2013

12 Ho GY, "Natural history of cervicovaginal papillomavirus infection in young women" 338 : 423-428, 1998

13 Schwebke JR, "Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial" 49 : 4106-4111, 2011

14 Winer RL, "Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students" 157 : 218-226, 2003

15 Harper DM, "Factors affecting the detection rate of human papillomavirus" 1 : 221-227, 2003

16 Fang J, "Evaluation of self-collected vaginal swab, first void urine, and endocervical swab specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent females" 21 : 355-360, 2008

17 Nouws S, "Epidemiology of human papillomavirus type 67 in Belgian women (OC 05-03)" EUROGIN 2016

18 Depuydt CE, "Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders" 70 : 273-280, 2010

19 Munoz N, "Epidemiologic classification of human papillomavirus types associated with cervical cancer" 348 : 518-527, 2003

20 Manhart LE, "Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis" 29 : 725-735, 2002

21 Baldwin S, "Comparison of type-specific human papillomavirus data from self and clinician directed sampling" 97 : 612-617, 2005

22 Else EA, "Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay" 49 : 1907-1912, 2011

23 Moscicki AB, "Comparison of natural histories of human papillomavirus detected by clinician- and self-sampling" 127 : 1882-1892, 2010

24 Mak R, "Cervical smears and human papillomavirus typing in sex workers" 80 : 118-120, 2004

25 Arbyn M, "Cervical cancer screening program and Human Papillomavirus (HPV) testing, part II: update on HPV primary screening"

26 Soohoo M, "Cervical HPV infection in female sex workers: a global perspective" 7 : 58-66, 2013

27 Yin YP, "Association of sexually transmitted infections with high-risk human papillomavirus types: a survey with 802 female sex workers in China" 40 : 493-495, 2013

28 Arbyn M, "Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis" 15 : 172-183, 2014